News | October 08, 2014

Cardinal Health Hosts Physician Panel on Balance of Clinical Excellence and Cost Effectiveness in Interventional Cardiology at TCT

October 8, 2014 — At the recent Transcatheter Cardiovascular Therapeutics (TCT) meeting, representatives from Cardinal Health and physicians from leading healthcare institutions led discussions to help interventionalists explore the balance between innovative approaches to lowering healthcare costs and maintaining high-quality patient care.

On Tuesday, Sept. 16, Cardinal Health Medical Segment CEO Don Casey discussed healthcare industry business model innovation before joining co-chair Martin B. Leon, M.D., from New York-Presbyterian Hospital/Columbia University Medical Center and panelists Michael Jaff, DO, from Massachusetts General Hospital; David Cohen, M.D., from Saint Luke’s Mid America Heart Institute; and Mark Burket, M.D., University of Toledo Medical Center for a panel entitled, “The Balance of Clinical Excellence and Cost-Effectiveness in Interventional Cardiology: Today and Tomorrow.”

“The healthcare system today, more than ever, needs new, innovative solutions that will allow providers to deliver great patient care while being fiscally prudent,” said Casey. “We believe there is an opportunity to build new solutions that combine product, services and analytics to bring more value to our customers.”

On the TCT show floor, Cardinal Health presented its interventional solution sets that help optimize interventional healthcare, including:

  • Operational efficiency — ensuring the right product in the right place at the right time from point of order to point of care;
  • Product quality — offering high-quality, cost-effective products from basic essentials to complex procedures to promote excellent patient care; and
  • Smart analytics — transforming data into actionable clinical, operational and financial insights.


For more information: www.cardinalhealth.com/interventional

Related Content

Shockwave Initiates U.S. Pivotal Study for Coronary Intravascular Lithotripsy
News | Cath Lab | January 16, 2019
Shockwave Medical Inc. has initiated its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE...
National Academy of Engineering, Ohio University Award 2019 Russ Prize
News | Cath Lab | January 03, 2019
Ohio University and the National Academy of Engineering announced the 2019 Fritz J. and Dolores H. Russ Prize will be...
Videos | Cath Lab | January 03, 2019
This is a walk through inside one of the cardiac hybrid cath labs at the...
Videos | Cath Lab | January 03, 2019
This is the newest cardiac cath lab at the ...
Study Finds Effective Treatment for Coronary Slow Flow
News | Cath Lab | December 27, 2018
Patients who arrive at the hospital with heart-attack-like symptoms have had little recourse for their chest pain if...
Shockwave Announces Collaboration With Abiomed on Physician Training
News | Cath Lab | December 14, 2018
Shockwave Medical announced a new investment and collaboration agreement with Abiomed Inc. As outlined by the agreement...
Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Overlay Init